APA (7th ed.) Citation

Olkus, A., Tomczak, A., Berger, A. K., Rauber, C., Puchas, P., Wehling, C., . . . Dill, M. T. (2024). Durvalumab plus gemcitabine and cisplatin in patients with advanced biliary tract cancer: An exploratory analysis of real-world data. Targeted oncology, 19(2), . https://doi.org/10.1007/s11523-024-01044-1

Chicago Style (17th ed.) Citation

Olkus, Alexander, et al. "Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-world Data." Targeted Oncology 19, no. 2 (2024). https://doi.org/10.1007/s11523-024-01044-1.

MLA (9th ed.) Citation

Olkus, Alexander, et al. "Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-world Data." Targeted Oncology, vol. 19, no. 2, 2024, https://doi.org/10.1007/s11523-024-01044-1.